DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 170 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,272 | – | 100 | +9900.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
Q1 2022 | $119,000 | -48.0% | 12,830 | -45.2% | 0.00% | – |
Q4 2021 | $229,000 | +151.6% | 23,424 | +770.1% | 0.00% | – |
Q3 2021 | $91,000 | -14.2% | 2,692 | -7.4% | 0.00% | – |
Q2 2021 | $106,000 | -27.9% | 2,907 | +12.5% | 0.00% | – |
Q4 2020 | $147,000 | +37.4% | 2,584 | -0.9% | 0.00% | -100.0% |
Q1 2020 | $107,000 | -85.6% | 2,607 | -78.2% | 0.00% | -80.0% |
Q4 2019 | $743,000 | +143.6% | 11,937 | +32.8% | 0.01% | +150.0% |
Q3 2019 | $305,000 | +771.4% | 8,990 | +898.9% | 0.00% | – |
Q3 2018 | $35,000 | – | 900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $18,687,872 | 15.44% |
Redmile Group, LLC | 5,582,105 | $86,243,522 | 3.74% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,218,638 | $80,627,957 | 1.80% |
BRAIDWELL LP | 3,241,351 | $50,078,873 | 1.65% |
Parkman Healthcare Partners LLC | 491,772 | $7,597,877 | 1.65% |
Sunesis Advisors, LLC | 96,299 | $1,487,820 | 1.07% |
ARMISTICE CAPITAL, LLC | 4,100,000 | $63,345,000 | 0.91% |
Deep Track Capital, LP | 1,363,201 | $21,061,455 | 0.86% |
AlphaCentric Advisors LLC | 72,500 | $1,120,125 | 0.77% |
Ikarian Capital, LLC | 174,510 | $2,696,179 | 0.61% |